These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 20515523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.
    Sottani C, Tranfo G, Faranda P, Minoia C.
    Rapid Commun Mass Spectrom; 2005; 19(19):2794-800. PubMed ID: 16144038
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry.
    Kasel D, Jetter A, Harlfinger S, Gebhardt W, Fuhr U.
    Rapid Commun Mass Spectrom; 2004; 18(13):1472-8. PubMed ID: 15216508
    [Abstract] [Full Text] [Related]

  • 7. Quantification of three antineoplastic agents in urine using the UniSpray ionisation source.
    Verscheure E, Creta M, Vanneste D, Vanoirbeek J, Zakia M, Abdesselam T, Lebegge R, Poels K, Ghosh M, Duca RC, Godderis L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Aug 01; 1205():123331. PubMed ID: 35752139
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry.
    Llewellyn N, Lloyd P, Jürgens MD, Johnson AC.
    J Chromatogr A; 2011 Nov 25; 1218(47):8519-28. PubMed ID: 22014384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ, Boer KA, Scheefhals AP, Anzion RB, Bos RP.
    Int Arch Occup Environ Health; 1992 Nov 25; 64(2):105-12. PubMed ID: 1399019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gas chromatographic determination of ifosfamide in microvolumes of urine and plasma.
    Kaijser GP, Beijnen JH, Bult A, Wiese G, de Kraker J, Underberg WJ.
    J Chromatogr; 1991 Nov 15; 571(1-2):121-31. PubMed ID: 1810941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Determination of cyclophosphamide and ifosphamide in urine at trace levels by gas chromatography/tandem mass spectrometry.
    Sannolo N, Miraglia N, Biglietto M, Acampora A, Malorni A.
    J Mass Spectrom; 1999 Aug 15; 34(8):845-9. PubMed ID: 10423565
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement.
    Sottani C, Turci R, Schierl R, Gaggeri R, Barbieri A, Violante FS, Minoia C.
    Rapid Commun Mass Spectrom; 2007 Aug 15; 21(7):1289-96. PubMed ID: 17340557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.